How will COVID-19 vaccine development inform HIV vaccine development
Barney Graham, M.D., Ph.D., Deputy Director Emeritus, Vaccine Research Center, Chief Emeritus, Viral Pathogenesis Laboratory, National Institutes of Health
Barney Graham, M.D., Ph.D., Deputy Director Emeritus, Vaccine Research Center, Chief Emeritus, Viral Pathogenesis Laboratory, National Institutes of Health
Ali Ellebedy, Ph.D., Associate Professor of Pathology and Immunology, Co-Director, Center for Vaccines and Immunity to Microbial Pathogens (CVIMP), Washington University School of Medicine
Presentation: Translational Clinical Research for HIV and COVID-19 Vaccine Development Speaker: Katy Stephenson, M.D., M.P.H., Principal Investigator and CTU Principal Investigator Clinical Trials Unit, Assistant Professor of Medicine, Harvard Medical School, Ragon Institute of MGH, MIT, and Harvard
Presentation: Clinical Studies of anti-HIV antibodies 3BNC117 and 10-1074 Speaker: Marina Caskey, M.D., Professor of Clinical Investigation, The Rockefeller University
Presents: “Virological and immunological characteristics of SARS-CoV-2 variants”
Sizun Jiang, Ph.D., Principal Investigator, Center for Virology and Vaccine Research Beth Israel Deaconess Medical Center, Affiliate Faculty, Department of Oncologic Pathology, Dana Farber Cancer Institute
Presentation: Functional Characterization of tissue-resident CD4 memory cells as a latent reservoir in SIV infected rhesus macaques Presenter: John Ventura, PhD Molecular Virology Lab Director Barouch Lab Center for Virology and Vaccine Research Beth Israel Deaconess Medical Center Harvard Medical School
Presentation: The “need to feed”: the neural and motivational basis for hunger as revealed using recombinase-enabled viruses in recombinase-expressing mice Speaker: Bradford Lowell, M.D., Ph.D., Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Department of Medicine and Program in Neuroscience, Harvard Medical School